Companies like Eli Lilly, Merck, GSK, Bristol-Meyers Squibb cause and perpetuate massive amounts of human suffering. I view them on the same level as Raytheon and Lockheed Martin. Input?

  • SnowySkyes
    ·
    5 个月前

    Treating cancer is more profitable than curing it. That’s really all anyone needs to know about that industry.

    • FourteenEyes [he/him]
      ·
      5 个月前

      "Cancer" is actually an umbrella term for a type of disease and there are over 200 kinds of cancer that require different approaches to treatment. We cannot have a "cure for cancer" anymore than a "cure for virus."

    • dannoffs [he/him]
      ·
      5 个月前

      I mean, a thing they can do is more profitable than a thing they can't, yes. What do you think cancer treatment is?

      • SnowySkyes
        ·
        edit-2
        5 个月前

        The problem being that there’s less of a profit incentive in researching a means to eliminate a disease rather than just treating individuals indefinitely.

        Perhaps cancer was a bad example, but I think it gets the point across.

      • Rx_Hawk [he/him]
        hexagon
        ·
        edit-2
        5 个月前

        Yeah, as soon as non-chemo, proton, etc. cancer cures are found they will be available to the upper-class, medical advancements aren't kept secret, but...

        Guess which form of cancer is at the forefront of research in terms of finding cures/prevention. Melanoma. Can you guess why?

        • JohnBrownsBussy2 [she/her, they/them]
          ·
          5 个月前

          Because it has a well understood oncogenesis, because immunotherapy and selective therapy drugs tend to work well against Melanomas, and because since it's localized in peripheral tissues it's easy to access and model?

          • Rx_Hawk [he/him]
            hexagon
            ·
            edit-2
            5 个月前

            Nah cause its for white people /hj

            • hexaflexagonbear [he/him]
              ·
              5 个月前

              All cancer treatments disproportionately benefit white people, as they can disproportionately afford them and disproportionately have better access to diagnostic tests. It actually wouldn't be sufficient to explain the difference in why melanoma treatments are more developed.